{
  "drugs": [
    {
      "drug": "temozolomide",
      "proteins": [
        "MGMT"
      ],
      "mechanism": "Alkylates O6-guanine; efficacy depends on MGMT silencing",
      "fda_status": "Approved (GBM, 2005)"
    },
    {
      "drug": "O6-benzylguanine",
      "proteins": [
        "MGMT"
      ],
      "mechanism": "Inactivates MGMT enzyme, potentiates alkylators",
      "fda_status": "Investigational"
    },
    {
      "drug": "MT-125",
      "proteins": [
        "MGMT"
      ],
      "mechanism": "Inhibits NMIIA/IIB to block invasion; RT synergy in MGMT-unmethylated GBM",
      "fda_status": "Fast-track (phase 1/2)"
    }
  ],
  "cancer_type": "glioblastoma",
  "protein_targets": [
    "MGMT"
  ]
}